ALK
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
SpliceBind: Isoform-Aware Prediction of Binding Pocket Druggability
arXiv:2606.04020v1 Announce Type: cross Abstract: Splice-mediated drug resistance occurs in up to 40% of patients on targeted kinase inhibitors, yet state-of-the-art druggability tools operate on single structures and cannot compare across isoforms. We introduce SpliceBind, a graph neural network framework for isoform-aware druggability prediction. Beyond improving prediction accuracy (AUROC 0.703 vs. P2Rank 0.634, p = 0.026), we address a more fundamental question: when do structural...
Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study
Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study Clinical trial finds 55 per cent of patients on lorlatinib experience no disease progression for at least seven years A Hong Kong co-led global study has found that a targeted therapy can keep more than half of advanced lung cancer patients alive without disease progression for at least seven years, marking a step towards turning the deadly illness into a chronic condition. Researchers from the Chinese...